BIOMAT Database Logo BIOMAT Database Logo

Ultrasonically guided 125iodine seed implantation with external radiation in management of localized prostatic carcinoma. 1989

P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
Department of Urology, University of Copenhagen, Denmark.

Thirty-three patients with localized prostatic carcinoma (16 poorly differentiated) were treated with transperineal 125Iodine seed implantation (160 Gy) guided by transrectal ultrasonography and subsequent external beam irradiation (47.4 Gy). The observation time was six to sixty-eight months with a median follow-up of thirty-five months. Median change in prostatic volume was a reduction of 35 percent. Re-biopsy or transurethral resection of the prostate was performed in 25 patients after one to two years, revealing still malignant histology in 12 (48%). Development of distant metastases occurred in 14 patients (44%), and 8 have died of prostatic cancer. Fourteen patients suffered from late complications of which surgical intervention was indicated in 3 cases.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography.
August 1983, The Journal of urology,
P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. 1983.
February 2002, The Journal of urology,
P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
Long-term results of ultrasonically guided implantation of 125-I seeds combined with external irradiation in localized prostatic cancer.
January 1991, Scandinavian journal of urology and nephrology. Supplementum,
P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
CT guided 125iodine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma.
December 2008, Chinese medical journal,
P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
Current trends in radiation management of localized prostatic carcinoma.
October 1999, The Australian and New Zealand journal of surgery,
P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
Iodine-125 implantation in the management of localized prostatic carcinoma.
October 1980, The Urologic clinics of North America,
P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
Transcoccygeal 125iodine prostatic implantation for adenocarcinoma.
March 1981, The Journal of urology,
P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
[CT guided radioactive 125I seed implantation in treating localized advanced pulmonary carcinoma].
December 2007, Zhonghua yi xue za zhi,
P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma.
September 1995, The Journal of urology,
P Iversen, and M Bak, and N Juul, and F Laursen, and H von der Maase, and L Nielsen, and F Rasmussen, and S Torp-Pedersen, and H H Holm
External radiation therapy of localized prostatic cancer.
January 1984, Journal of the National Medical Association,
Copied contents to your clipboard!